Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Investing Activities (2016 - 2025)

Haemonetics (HAE) has 17 years of Cash from Investing Activities data on record, last reported at -$29.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 69.63% year-over-year to -$29.5 million; the TTM value through Dec 2025 reached -$74.9 million, up 61.19%, while the annual FY2025 figure was -$161.9 million, 49.78% up from the prior year.
  • Cash from Investing Activities reached -$29.5 million in Q4 2025 per HAE's latest filing, up from -$30.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $18.0 million in Q1 2025 and bottomed at -$429.1 million in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$61.8 million, with a median of -$27.3 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: tumbled 850.7% in 2021, then surged 238.17% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$20.5 million in 2021, then plummeted by 77.88% to -$36.5 million in 2022, then crashed by 636.81% to -$268.9 million in 2023, then soared by 93.54% to -$17.4 million in 2024, then plummeted by 69.63% to -$29.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$29.5 million in Q4 2025, -$30.5 million in Q3 2025, and -$33.0 million in Q2 2025.